Endeavor

Moffitt Completes 100th Percutaneous Hepatic Perfusion Since FDA approval

The procedure helps improve uveal melanoma outcomes, which accounts for 3% to 5% of all melanoma cases and has a high likelihood of metastasizing to the liver

Collaboration and Inspiration at Heart of Society of Surgical Oncology Meeting

Surgeons who specialize in cancer care share ideas and trial data at annual meeting

This Summer Protect Your Eyes from UV Rays, Too

Wearing sunglasses, even on cloudy days, can keep your eyes safe

Character Actor Dies After Diagnosis of 2 Rare Cancers

Cholangiocarcinoma and ocular melanoma can both be treated with percutaneous hepatic perfusion, perfected at Moffitt

Eyeing New Therapies for Metastatic Uveal Melanoma

New $3.95 million multicenter grant will help researchers better understand the rare ocular cancer

Improving Standard of Care for Ocular Melanoma Patients with Liver Metastasis

Surgical procedure delivering chemotherapy directly to liver improves outcomes

Five Questions about Ocular Melanoma

Here are five questions to help you learn more about this rare cancer.

Eyes on a Rare Form of Melanoma

About 2,000 Americans are diagnosed with Ocular Melanoma each year.

Eye-Opening Facts about Ocular Melanoma

Outbreak of cases in Alabama and North Carolina draw attention to rare and potentially life-threatening eye cancer.